Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Runx3 deficiency results in myeloproliferative disorder in aged mice

Chelsia Qiuxia Wang, Lena Motoda, Masanobu Satake, Yoshiaki Ito, Ichiro Taniuchi, Vinay Tergaonkar, Motomi Osato

Blood (2013) 122 (4): 562–566.

https://doi.org/10.1182/blood-2012-10-460618

Published: 2013

Includes: Supplemental data

Journal Articles

Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis

Bindya Jacob, Motomi Osato, Namiko Yamashita, Chelsia Qiuxia Wang, Ichiro Taniuchi, Dan R. Littman, Norio Asou, Yoshiaki Ito

Blood (2010) 115 (8): 1610–1620.

https://doi.org/10.1182/blood-2009-07-232249

Published: 2010

Includes: Supplemental data

Journal Articles

PEBP2-β/CBF-β–dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis

Hee-Jun Wee, Dominic Chih-Cheng Voon, Suk-Chul Bae, Yoshiaki Ito

Blood (2008) 112 (9): 3777–3787.

https://doi.org/10.1182/blood-2008-01-134122

Published: 2008

Includes: Supplemental data

Journal Articles

Runx1 is involved in primitive erythropoiesis in the mouse

Tomomasa Yokomizo, Kazuteru Hasegawa, Hiroyuki Ishitobi, Motomi Osato, Masatsugu Ema, Yoshiaki Ito, Masayuki Yamamoto, Satoru Takahashi

Blood (2008) 111 (8): 4075–4080.

https://doi.org/10.1182/blood-2007-05-091637

Published: 2008

Journal Articles

Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia

Norio Asou, Masatoshi Yanagida, Liqun Huang, Masayuki Yamamoto, Katsuya Shigesada, Hiroaki Mitsuya, Yoshiaki Ito, Motomi Osato

Blood (2007) 109 (9): 4023–4027.

https://doi.org/10.1182/blood-2006-01-031781

Published: 2007

Includes: Supplemental data

Journal Articles

Identification of Marker Genes That Discriminate between Different Myeloproliferative Disorders and Normal Individuals Including RUNX3 (AML2).

Claudia I. Muller, MD, Quang T. Luong, PhD, Letetia C. Jones, PhD, Julian C. Desmond, PhD, Norihiko Kawamata, MD, PhD, Tcherniantchouk Tcherniantchouk, MD, Lee-Yung Shih, MD, Yoshiaki Ito, MD, PhD, Kosei Ito, PhD, Qiang Liu, PhD, Motomi Osato, MD, PhD, Sven de Vos, MD, H. Phillip Koeffler, MD

Blood (2005) 106 (11): 3522.

https://doi.org/10.1182/blood.V106.11.3522.3522

Published: 2005

Journal Articles

Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model

Masayuki Iwasaki, Takeshi Kuwata, Yukari Yamazaki, Nancy A. Jenkins, Neal G. Copeland, Motomi Osato, Yoshiaki Ito, Evert Kroon, Guy Sauvageau, Takuro Nakamura

Blood (2005) 105 (2): 784–793.

https://doi.org/10.1182/blood-2004-04-1508

Published: 2005

Includes: Supplemental data

Journal Articles

Identification of Cooperating Genetic Alterations in RUNX Leukemia Using the Mouse Model for the Human Familial Leukemia, FPD/AML.

Motomi Osato, MD, Namiko Yamashita, Masatoshi Yanagida, Liqun Huang, Scott Kogan, MD, Masayuki Iwasaki, PhD, Takuro Nakamura, MD, Katsuya Shigesada, PhD, Norio Asou, MD, PhD, Yoshiaki Ito, MD

Blood (2004) 104 (11): 3383.

https://doi.org/10.1182/blood.V104.11.3383.3383

Published: 2004

Journal Articles

Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera

Gang Huang, Katsuya Shigesada, Hee-Jun Wee, P. Paul Liu, Motomi Osato, Yoshiaki Ito

Blood (2004) 103 (8): 3200–3207.

https://doi.org/10.1182/blood-2003-07-2188

Published: 2004

Journal Articles

Heterozygous PU.1 mutations are associated with acute myeloid leukemia

Beatrice U. Mueller, Thomas Pabst, Motomi Osato, Norio Asou, Lisa M. Johansen, Mark D. Minden, Gerhard Behre, Wolfgang Hiddemann, Yoshiaki Ito, Daniel G. Tenen

Blood (2003) 101 (5): 2074.

https://doi.org/10.1182/blood-2002-12-3903

Published: 2003

Journal Articles

Heterozygous PU.1 mutations are associated with acute myeloid leukemia

Beatrice U. Mueller, Thomas Pabst, Motomi Osato, Norio Asou, Lisa M. Johansen, Mark D. Minden, Gerhard Behre, Wolfgang Hiddemann, Yoshiaki Ito, Daniel G. Tenen

Blood (2002) 100 (3): 998–1007.

https://doi.org/10.1182/blood.V100.3.998

Published: 2002

Journal Articles

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis

Joëlle Michaud, Feng Wu, Motomi Osato, Gregory M. Cottles, Masatoshi Yanagida, Norio Asou, Katsuya Shigesada, Yoshiaki Ito, Kathleen F. Benson, Wendy H. Raskind, Colette Rossier, Stylianos E. Antonarakis, Sara Israels, Archie McNicol, Harvey Weiss, Marshall Horwitz, Hamish S. Scott

Blood (2002) 99 (4): 1364–1372.

https://doi.org/10.1182/blood.V99.4.1364

Published: 2002

Journal Articles

Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia–associated TEL-AML1 oncoprotein

Fabien Guidez, Kevin Petrie, Anthony M. Ford, Huafeng Lu, Caroline A. Bennett, Angus MacGregor, Jürgen Hannemann, Yoshiaki Ito, Jacques Ghysdael, Mel Greaves, Leanne M. Wiedemann, Arthur Zelent

Blood (2000) 96 (7): 2557–2561.

https://doi.org/10.1182/blood.V96.7.2557

Published: 2000

Journal Articles

Biallelic and Heterozygous Point Mutations in the Runt Domain of the AML1/PEBP2B Gene Associated With Myeloblastic Leukemias

Motomi Osato, Norio Asou, Essam Abdalla, Koyu Hoshino, Hiroshi Yamasaki, Toshiya Okubo, Hitoshi Suzushima, Kiyoshi Takatsuki, Tomohiko Kanno, Katsuya Shigesada, Yoshiaki Ito

Blood (1999) 93 (6): 1817–1824.

https://doi.org/10.1182/blood.V93.6.1817.406k36_1817_1824

Published: 1999

NARROW

Runx3 deficiency results in myeloproliferative disorder in aged mice

Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis

PEBP2-β/CBF-β–dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis

Runx1 is involved in primitive erythropoiesis in the mouse

Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia

Identification of Marker Genes That Discriminate between Different Myeloproliferative Disorders and Normal Individuals Including RUNX3 (AML2).

Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model

Identification of Cooperating Genetic Alterations in RUNX Leukemia Using the Mouse Model for the Human Familial Leukemia, FPD/AML.

Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera

Heterozygous PU.1 mutations are associated with acute myeloid leukemia

Heterozygous PU.1 mutations are associated with acute myeloid leukemia

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis

Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia–associated TEL-AML1 oncoprotein

Biallelic and Heterozygous Point Mutations in the Runt Domain of the AML1/PEBP2B Gene Associated With Myeloblastic Leukemias

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only